 |
|
Reconstructed 1918 flu virus providing insights for potential pandemics
October 06, 2005Technique developed and patented by Mount Sinai School of Medicine researchers used to reconstruct 1918 virus
For the first time, this deadly 1918 Spanish flue virus has been reconstructed and characterized. This research, reported in this week's issue of Science, is part of a larger research initiative being led by Adolfo Garcia-Sastre, PhD, Professor of Microbiology and Peter Palese, PhD, Professor and Chairman of Microbiology at Mount Sinai School of Medicine. Their goal is to gain a greater understanding of this virus in order to use this knowledge to predict future pandemics and develop novel vaccines and treatments.
Drs. Garcia-Sastre and Palese and Christopher Basler, PhD, Assistant Professor of Microbiology worked with colleagues at the Centers for Disease Control, the Armed Forces Institute of Pathology in Maryland and The United States Department of Agriculture to characterize the 1918 virus. The reconstructed virus is contained at the CDC, following stringent safety conditions designated for flu viruses and other "select agents."
The virus was reconstructed using reverse genetics, a technique Drs. Garcia-Sastre and Palese developed. (See below for a description of the reverse genetics technique, which is being widely used in research to develop vaccines for a potential pandemic.)
The emergence of another pandemic is considered highly likely by many experts, but it is currently not possible to predict which viruses will become pandemics or how virulent a pandemic virus will be. Understanding the Spanish flu, the most virulent and deadly pandemic in recent history, may provide the information needed to anticipate which flu viruses have the potential to cause pandemics, determine in advance how virulent the virus is, and develop vaccines and treatments to prevent the potential devastation of a pandemic.
Three major discoveries about the virulence of the 1918 virus are included in the Science report:
1) It is extremely virulent in mice, leading to rapid death.
2) It is pathogenic in embryonated chicken eggs
* 3) It grows very rapidly in human lung cells.
All three of these are in contrast to most flu viruses that infect humans. These generally are not pathogenic in other species and grow significantly slower in human lung cells.
REVERSE GENETICS
Mounts Sinai School of Medicine researchers received US patent number 6,544,785 for a technique they developed to create viruses from DNA. The technique, known as reverse genetics or Plasmid Rescue Technology, is specifically designed to work with viruses that use RNA for storing their genetic material. Influenza is one such virus.
The genetic makeup of influenza viruses allows frequent minor genetic changes, known as antigenic drift, and these changes require annual reformulation of influenza vaccines. Each year the World Health Organization (WHO) works with health agencies in many countries to identify the strain(s) of influenza spreading in human populations. Once the strain(s) is isolated development of a vaccine begins. The slowness of the process is problematic even under the best of conditions, but should a particularly virulent strain such as the one that caused the pandemic of 1918 arise, delays in vaccine production could be catastrophic.
Based on historical patterns the WHO estimates that influenza pandemics can be expected to occur 3-4 times/century. A new pandemic is considered inevitable. "The speed of vaccine development will be particularly crucial when the next pandemic arrives," said Peter Palese, PhD, Chairman and Professor of Microbiology at Mount Sinai School of Medicine and one of the researchers listed on the patent.
While vaccines have been available for over 60 years, the length of time required for current methods of production is too long for effective response to a strain as virulent as the ones that have caused pandemics. Without reverse genetics, vaccine development is somewhat of a hit or miss procedure. Two strains are combining and nature takes its course until by chance a virus with the desired characteristics is obtained. A master strain is used to provide the desired growth qualities. This is combined with the form of the virus in circulation to obtain the proper antigenic qualities. After several generations of viruses have been produced, the resulting daughter strains are sorted through to identify which have the proper combination of characteristics.
Reverse genetics circumvents this usual procedure. Researchers can custom build a virus to meet their needs. The method is faster and also provides a means for researchers to alter the virus to have markers that allow safer handling and to eliminate pathogenic markers to enhance the safety of the vaccine. Custom building viruses for vaccines also facilitates greater quality control by reducing genetic variation in production.
The technique also makes practical the idea of developing a library of vaccines against a broad spectrum of avian viruses that have the potential to jump into humans. With such a stockpile, each year production of vaccines could begin as soon as circulating strains are identified.
The Mount Sinai Hospital / Mount Sinai School of M
The virus was reconstructed using reverse genetics, a technique Drs. Garcia-Sastre and Palese developed. (See below for a description of the reverse genetics technique, which is being widely used in research to develop vaccines for a potential pandemic.)
The emergence of another pandemic is considered highly likely by many experts, but it is currently not possible to predict which viruses will become pandemics or how virulent a pandemic virus will be. Understanding the Spanish flu, the most virulent and deadly pandemic in recent history, may provide the information needed to anticipate which flu viruses have the potential to cause pandemics, determine in advance how virulent the virus is, and develop vaccines and treatments to prevent the potential devastation of a pandemic.
Three major discoveries about the virulence of the 1918 virus are included in the Science report:
1) It is extremely virulent in mice, leading to rapid death.
2) It is pathogenic in embryonated chicken eggs
* 3) It grows very rapidly in human lung cells.
All three of these are in contrast to most flu viruses that infect humans. These generally are not pathogenic in other species and grow significantly slower in human lung cells.
REVERSE GENETICS
Mounts Sinai School of Medicine researchers received US patent number 6,544,785 for a technique they developed to create viruses from DNA. The technique, known as reverse genetics or Plasmid Rescue Technology, is specifically designed to work with viruses that use RNA for storing their genetic material. Influenza is one such virus.
The genetic makeup of influenza viruses allows frequent minor genetic changes, known as antigenic drift, and these changes require annual reformulation of influenza vaccines. Each year the World Health Organization (WHO) works with health agencies in many countries to identify the strain(s) of influenza spreading in human populations. Once the strain(s) is isolated development of a vaccine begins. The slowness of the process is problematic even under the best of conditions, but should a particularly virulent strain such as the one that caused the pandemic of 1918 arise, delays in vaccine production could be catastrophic.
Based on historical patterns the WHO estimates that influenza pandemics can be expected to occur 3-4 times/century. A new pandemic is considered inevitable. "The speed of vaccine development will be particularly crucial when the next pandemic arrives," said Peter Palese, PhD, Chairman and Professor of Microbiology at Mount Sinai School of Medicine and one of the researchers listed on the patent.
While vaccines have been available for over 60 years, the length of time required for current methods of production is too long for effective response to a strain as virulent as the ones that have caused pandemics. Without reverse genetics, vaccine development is somewhat of a hit or miss procedure. Two strains are combining and nature takes its course until by chance a virus with the desired characteristics is obtained. A master strain is used to provide the desired growth qualities. This is combined with the form of the virus in circulation to obtain the proper antigenic qualities. After several generations of viruses have been produced, the resulting daughter strains are sorted through to identify which have the proper combination of characteristics.
Reverse genetics circumvents this usual procedure. Researchers can custom build a virus to meet their needs. The method is faster and also provides a means for researchers to alter the virus to have markers that allow safer handling and to eliminate pathogenic markers to enhance the safety of the vaccine. Custom building viruses for vaccines also facilitates greater quality control by reducing genetic variation in production.
The technique also makes practical the idea of developing a library of vaccines against a broad spectrum of avian viruses that have the potential to jump into humans. With such a stockpile, each year production of vaccines could begin as soon as circulating strains are identified.
The Mount Sinai Hospital / Mount Sinai School of M
Scientists isolate genes that made 1918 flu lethal
By mixing and matching a contemporary flu virus with the "Spanish flu" - a virus that killed between 20 and 50 million people 90 years ago in history's most devastating outbreak of infectious disease - researchers have identified a set of three genes that helped underpin the extraordinary virulence of the 1918 virus.
Survivors of 1918 flu pandemic protected with a lifetime immunity to virus
New research has discovered that infection and natural exposure to the 1918 influenza virus made survivors immune to the disease for the remaining of their lives.
Study uncovers a lethal secret of 1918 influenza virus
In a study of non-human primates infected with the influenza virus that killed 50 million people in 1918, an international team of scientists has found a critical clue to how the virus killed so quickly and efficiently.
Experimental vaccine protects mice against deadly 1918 flu virus
Federal scientists have developed a vaccine that protects mice against the killer 1918 influenza virus.
Mouse study reveals new clues about virulence of 1918 influenza virus
The first comprehensive analysis of an animal's immune response to the 1918 influenza virus provides new insights into the killer flu, report federally supported scientists in an article appearing online today in the journal Nature.
More 1918 Flu Virus Current Events and 1918 Flu Virus News Articles
|
Research proceeding rapidly on novel H1N1 flu: influenza A(HIN1) is a direct descendant of the 1918 flu virus.(INFECTIOUS DISEASES): An article from: Pediatric News by Robert Finn (Author) This digital document is an article from Pediatric News, published by International Medical News Group on July 1, 2009. The length of the article is 1018 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Research proceeding rapidly on novel H1N1 flu: influenza A(HIN1) is a direct descendant of the 1918 flu virus.(INFECTIOUS DISEASES) Author: Robert Finn Publication: Pediatric News (Magazine/Journal) Date: July 1, 2009 Publisher: International Medical News Group Volume: 43 Issue: 7 Page: 9(1) Distributed by Gale, a part of Cengage... | |
|
A Doughboy's Lungs Yield 1918 Flu Virus / X-Ray Microprobe Unveils Biostructures / A Gene That Silences the X Chromosome / Molecular Motor Spins Out Energy for Cells / Working Memory May Fail in Schizophrenia (Science News, Volume 151, Number 12, March 22, 1997) by Julie Ann Miller (Editor) | |
 |
Flu: The Story Of The Great Influenza Pandemic of 1918 and the Search for the Virus that Caused It by Gina Kolata (Author) When we think of plagues, we think of AIDS, Ebola, anthrax spores, and, of course, the Black Death. But in 1918 the Great Flu Epidemic killed an estimated 40 million people virtually overnight. If such a plague returned today, taking a comparable percentage of the U.S. population with it, 1.5 million Americans would die. In Flu, Gina Kolata, an acclaimed reporter for The New York Times, unravels the mystery of this lethal virus with the high drama of a great adventure story. From Alaska to Norway, from the streets of Hong Kong to the corridors of the White House, Kolata tracks the race to recover the live pathogen and probes the fear that has impelled government policy. A gripping work of science writing, Flu addresses the prospects for a great epidemic's recurrence and... |
 |
Hunting the 1918 Flu: One Scientist's Search for a Killer Virus by Kirsty Duncan (Author) In 1918, medical science was at a loss to explain the Spanish flu epidemic, which swept the world in three great waves and killed an estimated 20 to 40 million people in just one year, more than the number that died during the four years of World War I. Today, while the Spanish flu has faded in the public's memory, most virologists are convinced that sooner or later a similarly deadly flu virus will return with a vengeance. Responding to this sustained interest in the Spanish flu, Kirsty Duncan in Hunting the 1918 Flu presents a detailed account of her experiences as she organized a multi-national, multi-discipline scientific expedition to exhume the bodies of a group of Norwegian miners, buried in Svalbard, all of whom died from the Spanish flu virus. Duncan weaves a twofold... |
|
Hunting the 1918 Flu: One Scientist's Search for a Killer Virus.(Book Review): An article from: The Geographical Review by Killian Ying (Author) This digital document is an article from The Geographical Review, published by American Geographical Society on January 1, 2004. The length of the article is 1179 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Hunting the 1918 Flu: One Scientist's Search for a Killer Virus.(Book Review) Author: Killian Ying Publication: The Geographical Review (Refereed) Date: January 1, 2004 Publisher: American Geographical Society Volume: 94 Issue: 1 Page: 128(3) Article Type: Book Review Distributed by Thomson... | |
 |
Flu: The Story of the Great Influenza Pandemic of 1918 & the Search for the Virus That Caused It by Gina Kolata (Author) |
|
Flu: The Story of the Great Influenza Pandemic of 1918 and the Search for The Virus that Caused It. by Gina. Kolata (Author) | |
|
Flu -- The Story of the Great Influenza Pandemic of 1918 and the Search for the Virus That Caused It by Pan, London (Publisher) | |
|
Flu: The Story of the Great Influenza Pandemic of 1918 and the Search for the Virus that Caused It by Gina Kolata (Author) | |
|
FLU, Story of the Great Influenza Pandemic of 1918 & Search for the Virus That Caused it by Gina Kolata (Author), b/w Photos (Illustrator) |
| © 2009 BrightSurf.com |